Danish Life Sciences Trend Analysis 2014

In 2013, the total venture financing value amassed by Danish Biotechnology companies was by 64% increased compared to the previous year’s figure (USD 82m in 2013 compared to USD 50m in 2012). This summer’s snapshot of the Danish biotech industry reveals that 1 in 10 biotech companies are publicly traded; a 4 percentage point increase from the same period last year.

Click here to download Danish Life Sciences Trend Analysis 2014 – 14 pages

Looking for your next Biotech or Medtech partner?

Use Biotechgate to identify new leads, licensing opportunities and management details.

One thought on “Danish Life Sciences Trend Analysis 2014”

Comments are closed.